150 related articles for article (PubMed ID: 24749004)
1. RAN GTPase and Osteopontin in Pancreatic Cancer.
Saxena S; Gandhi A; Lim PW; Relles D; Sarosiek K; Kang C; Chipitsyna G; Sendecki J; Yeo CJ; Arafat HA
Pancreat Disord Ther; 2013 Apr; 3(1):113. PubMed ID: 24749004
[TBL] [Abstract][Full Text] [Related]
2. Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic cancer cells.
Lazar M; Sullivan J; Chipitsyna G; Gong Q; Ng CY; Salem AF; Aziz T; Witkiewicz A; Denhardt DT; Yeo CJ; Arafat HA
J Gastrointest Surg; 2010 Oct; 14(10):1566-77. PubMed ID: 20824368
[TBL] [Abstract][Full Text] [Related]
3. Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.
Lazar M; Sullivan J; Chipitsyna G; Aziz T; Salem AF; Gong Q; Witkiewicz A; Denhardt DT; Yeo CJ; Arafat HA
Surgery; 2010 Aug; 148(2):298-309. PubMed ID: 20579680
[TBL] [Abstract][Full Text] [Related]
4. Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.
Sullivan J; Blair L; Alnajar A; Aziz T; Ng CY; Chipitsyna G; Gong Q; Witkiewicz A; Weber GF; Denhardt DT; Yeo CJ; Arafat HA
Surgery; 2009 Aug; 146(2):232-40. PubMed ID: 19628079
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma.
Sullivan J; Blair L; Alnajar A; Aziz T; Chipitsyna G; Gong Q; Yeo CJ; Arafat HA
Histol Histopathol; 2011 Jul; 26(7):893-904. PubMed ID: 21630219
[TBL] [Abstract][Full Text] [Related]
6. Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells.
Chipitsyna G; Gong Q; Anandanadesan R; Alnajar A; Batra SK; Wittel UA; Cullen DM; Akhter MP; Denhardt DT; Yeo CJ; Arafat HA
Int J Cancer; 2009 Jul; 125(2):276-85. PubMed ID: 19358273
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions.
Kolb A; Kleeff J; Guweidhi A; Esposito I; Giese NA; Adwan H; Giese T; Büchler MW; Berger MR; Friess H
Cancer Biol Ther; 2005 Jul; 4(7):740-6. PubMed ID: 15970685
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma.
Siddiqui AA; Jones E; Andrade D; Shah A; Kowalski TE; Loren DE; Chipitsyna G; Arafat HA
J Gastroenterol Hepatol; 2014 Jun; 29(6):1321-7. PubMed ID: 24548099
[TBL] [Abstract][Full Text] [Related]
9. Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4.
Deng L; Shang Y; Guo S; Liu C; Zhou L; Sun Y; Nie Y; Fan D; Lu Y; Guo X
Cancer Biol Ther; 2014 Aug; 15(8):1087-93. PubMed ID: 24840182
[TBL] [Abstract][Full Text] [Related]
10. RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.
Kurisetty VV; Johnston PG; Johnston N; Erwin P; Crowe P; Fernig DG; Campbell FC; Anderson IP; Rudland PS; El-Tanani MK
Oncogene; 2008 Dec; 27(57):7139-49. PubMed ID: 18794800
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.
Sarosiek K; Jones E; Chipitsyna G; Al-Zoubi M; Kang C; Saxena S; Gandhi AV; Sendiky J; Yeo CJ; Arafat HA
J Gastrointest Surg; 2015 Apr; 19(4):639-50. PubMed ID: 25583441
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma.
Collins AL; Rock J; Malhotra L; Frankel WL; Bloomston M
Ann Surg Oncol; 2012 Aug; 19(8):2673-8. PubMed ID: 22461132
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinoma.
Gandhi AV; Saxena S; Relles D; Sarosiek K; Kang CY; Chipitsyna G; Sendecki JA; Yeo CJ; Arafat HA
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S636-43. PubMed ID: 23846787
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer.
Tang X; Li J; Yu B; Su L; Yu Y; Yan M; Liu B; Zhu Z
Int J Biol Sci; 2013; 9(1):55-66. PubMed ID: 23289017
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma.
Terashi T; Aishima S; Taguchi K; Asayama Y; Sugimachi K; Matsuura S; Shimada M; Maehara S; Maehara Y; Tsuneyoshi M
Liver Int; 2004 Feb; 24(1):38-45. PubMed ID: 15101999
[TBL] [Abstract][Full Text] [Related]
19. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.
Kim JY; Bae BN; Kim KS; Shin E; Park K
Cancer Res Treat; 2009 Mar; 41(1):29-35. PubMed ID: 19688069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
